Literature DB >> 965377

Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Balpha and M2Bbeta.

W M Kemper, K W Berry, W C Merrick.   

Abstract

The active protein components of initiation factor M2B (IF-M2B) have been resolved into two homogeneous factors. These proteins, IF-M2Balpha and IF-M2Bbeta, were purified 300- and 500-fold, respectively, with a yield of about 15% of the original starting activity. The low molecular weight (approximately 17,000) of these two proteins is in contrast with the much greater molecular weights that have been found for other initiation factors. IF-M2Balpha is also unique among the initiation factors in that it contains no tryptophan and is capable of self-association. Both proteins are required for model assays which utilize 40 S and 60 S subunits (poly(U)-directed polyphenylalanine synthesis or AUG-directed methionyl-puromycin synthesis). IF-M2Bbeta has been shown to be required for hemoglobin synthesis, however, the presence of high concentrations of IF-M2Balpha in the 100,000 X g lysate supernatant has precluded the demonstration of an IF-M2Balpha requirement in hemoglobin synthesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 965377

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Changes in gene expression in response to polyamine depletion indicates selective stabilization of mRNAs.

Authors:  I Veress; S Haghighi; A Pulkka; A Pajunen
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes.

Authors:  G Lipowsky; F R Bischoff; P Schwarzmaier; R Kraft; S Kostka; E Hartmann; U Kutay; D Görlich
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

3.  mRNP proteins, initiation factors and phosphorylation.

Authors:  J M Egly; R Elkaim; M Pierre
Journal:  Mol Biol Rep       Date:  1979-05-31       Impact factor: 2.316

4.  A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA.

Authors:  N Sonenberg; M A Morgan; W C Merrick; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Revisiting an old acquaintance: role for eIF5A in diabetes.

Authors:  Joachim Hauber
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

6.  The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.

Authors:  Bernhard Maier; Takeshi Ogihara; Anthony P Trace; Sarah A Tersey; Reiesha D Robbins; Swarup K Chakrabarti; Craig S Nunemaker; Natalie D Stull; Catherine A Taylor; John E Thompson; Richard S Dondero; Eli C Lewis; Charles A Dinarello; Jerry L Nadler; Raghavendra G Mirmira
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 7.  Hydroxylation and translational adaptation to stress: some answers lie beyond the STOP codon.

Authors:  M J Katz; L Gándara; A L De Lella Ezcurra; P Wappner
Journal:  Cell Mol Life Sci       Date:  2016-02-13       Impact factor: 9.261

8.  Translation Initiation Site Profiling Reveals Widespread Synthesis of Non-AUG-Initiated Protein Isoforms in Yeast.

Authors:  Amy R Eisenberg; Andrea L Higdon; Ina Hollerer; Alexander P Fields; Irwin Jungreis; Paige D Diamond; Manolis Kellis; Marko Jovanovic; Gloria A Brar
Journal:  Cell Syst       Date:  2020-07-24       Impact factor: 10.304

9.  Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.

Authors:  J Katahira; T Ishizaki; H Sakai; A Adachi; K Yamamoto; H Shida
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Translational control of inducible nitric oxide synthase by p38 MAPK in islet β-cells.

Authors:  Yurika Nishiki; Adeola Adewola; Masayuki Hatanaka; Andrew T Templin; Bernhard Maier; Raghavendra G Mirmira
Journal:  Mol Endocrinol       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.